Showing results (1-10 of 118) with videos related to
Sort By:
Pageof 12
Neoplasia (New York, N.Y.)|January 5, 2002
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosisB Fingleton, T Vargo-Gogola, H C Crawford, et al.Current Opinion in Oncology|September 14, 2001
Matrix metalloproteinases as targets for therapy in Kaposi sarcomaB Fingleton, L M MatrisianThe Journal of Clinical Investigation|January 22, 2000
Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorptionH Haro, H C Crawford, B Fingleton, et al.The Journal of Clinical Investigation|January 22, 2000
Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorptionH Haro, H C Crawford, B Fingleton, et al.Invasion & Metastasis|January 1, 1994
Tumor and stromal expression of matrix metalloproteinases and their role in tumor progressionH C Crawford, L M MatrisianEnzyme & Protein|January 1, 1996
Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cellsH C Crawford, L M MatrisianMolecular and Cellular Biology|February 7, 2001
The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumorsH C Crawford, B Fingleton, M D Gustavson, et al.Journal of Cell Science|December 12, 2000
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1V Noë, B Fingleton, K Jacobs, et al.Cancer Research|November 21, 1998
Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivoH C Crawford, L M Matrisian, L LiawJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Matrix metalloproteinases: biologic activity and clinical implicationsA R Nelson, B Fingleton, M L Rothenberg, et al.Pageof 12